127 related articles for article (PubMed ID: 11686976)
1. Polysaccharide vaccines for preventing serogroup A meningococcal meningitis.
Patel M; Lee CK
Cochrane Database Syst Rev; 2001; (3):CD001093. PubMed ID: 11686976
[TBL] [Abstract][Full Text] [Related]
2. Polysaccharide vaccines for preventing serogroup A meningococcal meningitis.
Patel M; Lee CK
Cochrane Database Syst Rev; 2005 Jan; (1):CD001093. PubMed ID: 15674874
[TBL] [Abstract][Full Text] [Related]
3. Polysaccharide vaccines for preventing serogroup A meningococcal meningitis.
Patel M
Cochrane Database Syst Rev; 2000; (2):CD001093. PubMed ID: 10796590
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.
Noronha CP; Struchiner CJ; Halloran ME
Int J Epidemiol; 1995 Oct; 24(5):1050-7. PubMed ID: 8557439
[TBL] [Abstract][Full Text] [Related]
5. Conjugate vaccines for preventing meningococcal C meningitis and septicaemia.
Conterno LO; Silva Filho CR; Rüggeberg JU; Heath PT
Cochrane Database Syst Rev; 2006 Jul; (3):CD001834. PubMed ID: 16855979
[TBL] [Abstract][Full Text] [Related]
6. WITHDRAWN: Conjugate vaccines for preventing meningococcal C meningitis and septicaemia.
Conterno LO; da Silva Filho CR; Ruggeberg JU; Heath PT
Cochrane Database Syst Rev; 2011 Jul; 2011(7):CD001834. PubMed ID: 21735387
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of the meningococcal vaccine from Group C capsular polysaccharide].
González Enríquez J; García Comas L; Alcaide Jiménez JF; Sáenz Calvo A; Conde Olasagasti J
Rev Esp Salud Publica; 1997; 71(2):103-26. PubMed ID: 9546855
[TBL] [Abstract][Full Text] [Related]
8. [Analysis for protection rate and antibody levels of epidemic cerebrospinal meningitis among children aged between 3-23 months in Liuzhou, in 2012].
Cui XL; Wu X; Li MQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec; 50(12):1079-1083. PubMed ID: 28057112
[No Abstract] [Full Text] [Related]
9. A serogroup A meningococcal polysaccharide vaccine: studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A.
Erwa HH; Haseeb MA; Idris AA; Lapeyssonnie L; Sanborn WR; Sippel JE
Bull World Health Organ; 1973; 49(3):301-5. PubMed ID: 4211056
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.
Robertson CA; Greenberg DP; Hedrick J; Pichichero M; Decker MD; Saunders M
Vaccine; 2016 Oct; 34(44):5273-5278. PubMed ID: 27642132
[TBL] [Abstract][Full Text] [Related]
11. Meningococcal serogroup C immunogenicity, antibody persistence and memory B-cells induced by the monovalent meningococcal serogroup C versus quadrivalent meningococcal serogroup ACWY conjugate booster vaccine: A randomized controlled trial.
van Ravenhorst MB; van der Klis FRM; van Rooijen DM; Knol MJ; Stoof SP; Sanders EAM; Berbers GAM
Vaccine; 2017 Aug; 35(36):4745-4752. PubMed ID: 28668575
[TBL] [Abstract][Full Text] [Related]
12. Meningococcal serogroup C serum and salivary antibody responses to meningococcal quadrivalent conjugate vaccine in Saudi Arabian adolescents previously vaccinated with bivalent and quadrivalent meningococcal polysaccharide vaccine.
Khalil M; Al-Mazrou Y; Findlow H; Chadha H; Bosch Castells V; Oster P; Borrow R
Vaccine; 2014 Sep; 32(43):5715-21. PubMed ID: 25151042
[TBL] [Abstract][Full Text] [Related]
13. Meningococcal conjugate vaccines: efficacy and new combinations.
Sáfadi MA; Barros AP
J Pediatr (Rio J); 2006 Jul; 82(3 Suppl):S35-44. PubMed ID: 16826310
[TBL] [Abstract][Full Text] [Related]
14. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial.
MacDonald NE; Halperin SA; Law BJ; Forrest B; Danzig LE; Granoff DM
JAMA; 1998 Nov; 280(19):1685-9. PubMed ID: 9832000
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of safety of meningococcal group AC bivalent polysaccharide conjugate vaccine in children aged 5-24 months old].
Zhou H; Wang JY; Tan Y; Lü HY; Wang M; Cai QC; Zhang HZ
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Oct; 47(10):920-3. PubMed ID: 24378132
[TBL] [Abstract][Full Text] [Related]
16. Prevention of bacterial meningitis: an overview of Cochrane systematic reviews.
Prasad K; Karlupia N
Respir Med; 2007 Oct; 101(10):2037-43. PubMed ID: 17706408
[TBL] [Abstract][Full Text] [Related]
17. Antibody responses to meningococcal (groups A, C, Y and W135) polysaccharide diphtheria toxoid conjugate vaccine in children who previously received meningococcal C conjugate vaccine.
El Bashir H; Heath PT; Papa T; Ruggeberg JU; Johnson N; Sinha R; Balfour G; Booy R
Vaccine; 2006 Mar; 24(14):2544-9. PubMed ID: 16417952
[TBL] [Abstract][Full Text] [Related]
18. Vaccines for the prevention of meningococcal disease in children.
Soriano-Gabarró M; Stuart JM; Rosenstein NE
Semin Pediatr Infect Dis; 2002 Jul; 13(3):182-9. PubMed ID: 12199614
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of the multicomponent meningococcal B vaccine (4CMenB) in children and adolescents: a systematic review and meta-analysis.
Flacco ME; Manzoli L; Rosso A; Marzuillo C; Bergamini M; Stefanati A; Cultrera R; Villari P; Ricciardi W; Ioannidis JPA; Contopoulos-Ioannidis DG
Lancet Infect Dis; 2018 Apr; 18(4):461-472. PubMed ID: 29371070
[TBL] [Abstract][Full Text] [Related]
20. Serogroup B meningococcal vaccines.
Zimmer SM; Stephens DS
Curr Opin Investig Drugs; 2006 Aug; 7(8):733-9. PubMed ID: 16955685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
